Connection

KAZUHIRO OKA to Animals

This is a "connection" page, showing publications KAZUHIRO OKA has written about Animals.
Connection Strength

0.306
  1. Gene therapy for rhesus monkeys heterozygous for LDL receptor deficiency by balloon catheter hepatic delivery of helper-dependent adenoviral vector. Gene Ther. 2015 Jan; 22(1):87-95.
    View in: PubMed
    Score: 0.025
  2. Interleukin-7 induces recruitment of monocytes/macrophages to endothelium. Eur Heart J. 2012 Dec; 33(24):3114-23.
    View in: PubMed
    Score: 0.020
  3. A neuronal VLDLR variant lacking the third complement-type repeat exhibits high capacity binding of apoE containing lipoproteins. Brain Res. 2009 Jun 18; 1276:11-21.
    View in: PubMed
    Score: 0.017
  4. Sustained phenotypic correction in a mouse model of hypoalphalipoproteinemia with a helper-dependent adenovirus vector. Gene Ther. 2007 Feb; 14(3):191-202.
    View in: PubMed
    Score: 0.014
  5. Targeting site-specific chromosome integration. Acta Biochim Pol. 2005; 52(2):285-91.
    View in: PubMed
    Score: 0.013
  6. Inhibition and regression of atherosclerotic lesions. Acta Biochim Pol. 2005; 52(2):311-9.
    View in: PubMed
    Score: 0.013
  7. Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor. Circulation. 2001 Mar 06; 103(9):1274-81.
    View in: PubMed
    Score: 0.010
  8. Recent advances in liver-directed gene therapy: implications for the treatment of dyslipidemia. Curr Opin Lipidol. 2000 Apr; 11(2):179-86.
    View in: PubMed
    Score: 0.009
  9. Tissue-specific inhibition of apolipoprotein B mRNA editing in the liver by adenovirus-mediated transfer of a dominant negative mutant APOBEC-1 leads to increased low density lipoprotein in mice. J Biol Chem. 1997 Jan 17; 272(3):1456-60.
    View in: PubMed
    Score: 0.007
  10. Cholesterol Accumulation in CD11c+ Immune Cells Is a Causal and Targetable Factor in Autoimmune Disease. Immunity. 2016 12 20; 45(6):1311-1326.
    View in: PubMed
    Score: 0.007
  11. Functional Differences of Very-Low-Density Lipoprotein Receptor Splice Variants in Regulating Wnt Signaling. Mol Cell Biol. 2016 10 15; 36(20):2645-54.
    View in: PubMed
    Score: 0.007
  12. Enhanced atheroprotection and lesion remodelling by targeting the foam cell and increasing plasma cholesterol acceptors. Cardiovasc Res. 2016 Feb 01; 109(2):294-304.
    View in: PubMed
    Score: 0.007
  13. Partial structure of the mouse glucokinase gene. Genomics. 1995 Oct 10; 29(3):751-4.
    View in: PubMed
    Score: 0.007
  14. Gene therapy with neurogenin3, betacellulin and SOCS1 reverses diabetes in NOD mice. Gene Ther. 2015 Nov; 22(11):876-82.
    View in: PubMed
    Score: 0.007
  15. Effects of High Fat Feeding and Diabetes on Regression of Atherosclerosis Induced by Low-Density Lipoprotein Receptor Gene Therapy in LDL Receptor-Deficient Mice. PLoS One. 2015; 10(6):e0128996.
    View in: PubMed
    Score: 0.007
  16. PD-L1-driven tolerance protects neurogenin3-induced islet neogenesis to reverse established type 1 diabetes in NOD mice. Diabetes. 2015 Feb; 64(2):529-40.
    View in: PubMed
    Score: 0.006
  17. Mouse very-low-density-lipoprotein receptor (VLDLR) cDNA cloning, tissue-specific expression and evolutionary relationship with the low-density-lipoprotein receptor. Eur J Biochem. 1994 Sep 15; 224(3):975-82.
    View in: PubMed
    Score: 0.006
  18. Meiosis-specific cohesin component, Stag3 is essential for maintaining centromere chromatid cohesion, and required for DNA repair and synapsis between homologous chromosomes. PLoS Genet. 2014 Jul; 10(7):e1004413.
    View in: PubMed
    Score: 0.006
  19. Gene therapy for neuropathic pain by silencing of TNF-a expression with lentiviral vectors targeting the dorsal root ganglion in mice. PLoS One. 2014; 9(3):e92073.
    View in: PubMed
    Score: 0.006
  20. Human very-low-density lipoprotein receptor complementary DNA and deduced amino acid sequence and localization of its gene (VLDLR) to chromosome band 9p24 by fluorescence in situ hybridization. Genomics. 1994 Mar 15; 20(2):298-300.
    View in: PubMed
    Score: 0.006
  21. Mutant cohesin in premature ovarian failure. N Engl J Med. 2014 Mar 06; 370(10):943-949.
    View in: PubMed
    Score: 0.006
  22. [Structure and regulation of hepatic lipase]. Seikagaku. 1993 Dec; 65(12):1516-21.
    View in: PubMed
    Score: 0.006
  23. Haematopoietic cells produce BDNF and regulate appetite upon migration to the hypothalamus. Nat Commun. 2013; 4:1526.
    View in: PubMed
    Score: 0.006
  24. Neo-islet formation in liver of diabetic mice by helper-dependent adenoviral vector-mediated gene transfer. J Vis Exp. 2012 Oct 10; (68).
    View in: PubMed
    Score: 0.006
  25. Carbohydrate response element-binding protein (ChREBP) plays a pivotal role in beta cell glucotoxicity. Diabetologia. 2012 Jun; 55(6):1783-96.
    View in: PubMed
    Score: 0.005
  26. CREB-activity and nmnat2 transcription are down-regulated prior to neurodegeneration, while NMNAT2 over-expression is neuroprotective, in a mouse model of human tauopathy. Hum Mol Genet. 2012 Jan 15; 21(2):251-67.
    View in: PubMed
    Score: 0.005
  27. Liver-specific expression of an exogenous gene controlled by human apolipoprotein A-I promoter. Int J Pharm. 2010 Oct 15; 398(1-2):161-4.
    View in: PubMed
    Score: 0.005
  28. DRG-targeted helper-dependent adenoviruses mediate selective gene delivery for therapeutic rescue of sensory neuronopathies in mice. J Clin Invest. 2009 Jul; 119(7):2100-112.
    View in: PubMed
    Score: 0.004
  29. Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity. Arterioscler Thromb Vasc Biol. 2009 Jun; 29(6):843-9.
    View in: PubMed
    Score: 0.004
  30. Neurogenin3 is sufficient for transdetermination of hepatic progenitor cells into neo-islets in vivo but not transdifferentiation of hepatocytes. Dev Cell. 2009 Mar; 16(3):358-73.
    View in: PubMed
    Score: 0.004
  31. Gene therapy for diabetes: metabolic effects of helper-dependent adenoviral exendin 4 expression in a diet-induced obesity mouse model. Mol Ther. 2008 11; 16(11):1805-12.
    View in: PubMed
    Score: 0.004
  32. Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice. Proc Natl Acad Sci U S A. 2008 Feb 12; 105(6):2082-7.
    View in: PubMed
    Score: 0.004
  33. Aggressive very low-density lipoprotein (VLDL) and LDL lowering by gene transfer of the VLDL receptor combined with a low-fat diet regimen induces regression and reduces macrophage content in advanced atherosclerotic lesions in LDL receptor-deficient mice. Am J Pathol. 2006 Jun; 168(6):2064-73.
    View in: PubMed
    Score: 0.004
  34. Suppression of atherosclerotic plaque progression and instability by tissue inhibitor of metalloproteinase-2: involvement of macrophage migration and apoptosis. Circulation. 2006 May 23; 113(20):2435-44.
    View in: PubMed
    Score: 0.004
  35. Regulatable atrial natriuretic peptide gene therapy for hypertension. Proc Natl Acad Sci U S A. 2005 Sep 27; 102(39):13789-94.
    View in: PubMed
    Score: 0.003
  36. Low-density lipoprotein receptor gene therapy using helper-dependent adenovirus produces long-term protection against atherosclerosis in a mouse model of familial hypercholesterolemia. Gene Ther. 2004 Oct; 11(20):1540-8.
    View in: PubMed
    Score: 0.003
  37. Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice. Gene. 2004 Mar 03; 327(2):153-60.
    View in: PubMed
    Score: 0.003
  38. Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia. Circulation. 2003 Jun 03; 107(21):2726-32.
    View in: PubMed
    Score: 0.003
  39. Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector. Proc Natl Acad Sci U S A. 2001 Nov 06; 98(23):13282-7.
    View in: PubMed
    Score: 0.003
  40. The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding. Metabolism. 2000 Jan; 49(1):22-31.
    View in: PubMed
    Score: 0.002
  41. Apolipoprotein B: from editosome to proteasome. Recent Prog Horm Res. 2000; 55:93-125; discussion 126.
    View in: PubMed
    Score: 0.002
  42. Mouse very low-density lipoprotein receptor (VLDLR): gene structure, tissue-specific expression and dietary and developmental regulation. Atherosclerosis. 1999 Aug; 145(2):239-51.
    View in: PubMed
    Score: 0.002
  43. Production of rabbit polyclonal antibody against apobec-1 by genetic immunization. J Lipid Res. 1997 Dec; 38(12):2627-32.
    View in: PubMed
    Score: 0.002
  44. Failure of the nonselective beta-blocker propranolol to affect lipoprotein lipase gene expression in the rat. Lipids. 1997 Sep; 32(9):943-7.
    View in: PubMed
    Score: 0.002
  45. Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1. J Biol Chem. 1996 Oct 18; 271(42):25981-8.
    View in: PubMed
    Score: 0.002
  46. Reversal of hypercholesterolemia in low density lipoprotein receptor knockout mice by adenovirus-mediated gene transfer of the very low density lipoprotein receptor. J Biol Chem. 1996 Mar 22; 271(12):6852-60.
    View in: PubMed
    Score: 0.002
  47. Tissue-specific expression and cholesterol regulation of acylcoenzyme A:cholesterol acyltransferase (ACAT) in mice. Molecular cloning of mouse ACAT cDNA, chromosomal localization, and regulation of ACAT in vivo and in vitro. J Biol Chem. 1995 Nov 03; 270(44):26192-201.
    View in: PubMed
    Score: 0.002
  48. Alternative mRNA splicing and differential promoter utilization determine tissue-specific expression of the apolipoprotein B mRNA-editing protein (Apobec1) gene in mice. Structure and evolution of Apobec1 and related nucleoside/nucleotide deaminases. J Biol Chem. 1995 Jun 02; 270(22):13042-56.
    View in: PubMed
    Score: 0.002
  49. Structure of the mouse cholesterol 7 alpha-hydroxylase gene. Genomics. 1994 May 01; 21(1):244-7.
    View in: PubMed
    Score: 0.002
  50. Endotoxin-induced hypertriglyceridemia is mediated by suppression of lipoprotein lipase at a post-transcriptional level. J Lipid Res. 1993 Jan; 34(1):139-46.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.